Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

200 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term cost effectiveness of early and sustained dual oral antiplatelet therapy with clopidogrel given for up to one year after percutaneous coronary intervention results: from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial.
Beinart SC, Kolm P, Veledar E, Zhang Z, Mahoney EM, Bouin O, Gabriel S, Jackson J, Chen R, Caro J, Steinhubl S, Topol E, Weintraub WS. Beinart SC, et al. Among authors: kolm p. J Am Coll Cardiol. 2005 Sep 6;46(5):761-9. doi: 10.1016/j.jacc.2005.03.073. J Am Coll Cardiol. 2005. PMID: 16139122 Free article. Clinical Trial.
Cost in the use of enoxaparin compared with unfractionated heparin in patients with atrial fibrillation undergoing a transesophageal echocardiography-guided cardioversion (from Assessment of Cardioversion using Transesophageal Echocardiography [ACUTE] II randomized multicenter study).
Zhao L, Zhang Z, Kolm P, Jasper S, Lewis C, Klein A, Weintraub W; ACUTE II Investigators. Zhao L, et al. Among authors: kolm p. Am J Cardiol. 2008 Feb 1;101(3):338-42. doi: 10.1016/j.amjcard.2007.09.075. Am J Cardiol. 2008. PMID: 18237596 Clinical Trial.
Long-term cost-effectiveness of clopidogrel in STEMI patients.
Zhang Z, Kolm P, Mosse F, Jackson J, Zhao L, Weintraub WS. Zhang Z, et al. Among authors: kolm p. Int J Cardiol. 2009 Jul 10;135(3):353-60. doi: 10.1016/j.ijcard.2008.04.011. Epub 2008 Jun 30. Int J Cardiol. 2009. PMID: 18586338 Clinical Trial.
Cost-effectiveness of eplerenone compared with placebo in patients with myocardial infarction complicated by left ventricular dysfunction and heart failure.
Weintraub WS, Zhang Z, Mahoney EM, Kolm P, Spertus JA, Caro J, Ishak J, Goldberg R, Tooley J, Willke R, Pitt B. Weintraub WS, et al. Among authors: kolm p. Circulation. 2005 Mar 8;111(9):1106-13. doi: 10.1161/01.CIR.0000157146.86758.BC. Epub 2005 Feb 21. Circulation. 2005. PMID: 15723981 Clinical Trial.
Cost effectiveness of enoxaparin in acute ST-segment elevation myocardial infarction: the ExTRACT-TIMI 25 (Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction 25) study.
Marcoff L, Zhang Z, Zhang W, Ewen E, Jurkovitz C, Leguet P, Kolm P, Weintraub WS. Marcoff L, et al. Among authors: kolm p. J Am Coll Cardiol. 2009 Sep 29;54(14):1271-9. doi: 10.1016/j.jacc.2009.05.060. J Am Coll Cardiol. 2009. PMID: 19778669 Free article. Clinical Trial.
Economics methods in the Clinical Outcomes Utilizing percutaneous coronary Revascularization and Aggressive Guideline-driven drug Evaluation (COURAGE) trial.
Weintraub WS, Barnett P, Chen S, Hartigan P, Casperson P, O'Rourke R, Boden WE, Lewis C, Veledar E, Becker E, Culler S, Kolm P, Mahoney EM, Dunbar SB, Deaton C, O'Brien B, Goeree R, Blackhouse G, Nease R, Spertus J, Kaufman S, Teo K. Weintraub WS, et al. Among authors: kolm p. Am Heart J. 2006 Jun;151(6):1180-5. doi: 10.1016/j.ahj.2005.07.035. Am Heart J. 2006. PMID: 16781215
200 results